Ziopharm Oncology to Report Second Quarter Financial Results on August 9, 2021

NEXT STORY
Brown & Brown, Inc. Announces Quarterly Revenues of $727.3 Million, an Increase of 21.5%, and Diluted Net Income Per Share of $0.49
PREV STORY
Lumos Pharma Appoints Pediatric Endocrinologist Experienced in Clinical Research and Pharmaceutical Development, Mark Bach, M.D., Ph.D., to Clinical Scientific Advisory Board
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

TiGenix to present at the Jefferies 2017 Global Healthcare Conference in New York

PRESS RELEASE TiGenix to present at the Jefferies 2017 Global Healthcare Conference in New ...

author_avatar
NASDAQ Market News

VFMCRP AND CARA THERAPEUTICS TO DEVELOP AND COMMERCIALISE CR845 INJECTION FOR CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) to develop and commercialise CR845/difelikefalin injection worldwide ...

author_avatar
NASDAQ Market News

Actinium Pharmaceuticals Appoints Dr. Dale L. Ludwig, Ph.D. as Chief Scientific Officer to Lead Efforts Focused on the Company’s AWE Technology Platform and Research Programs

- Dr. Ludwig brings over 20 years of leadership and management expertise from Eli ...

author_avatar
NASDAQ Market News